← Back to patent-cliff list
Medical Cannabis(Syqe Medical)
Tier C — Watch / tradeMedical Cannabis(Syqe Medical)
Syqe Medical Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：CB
Brand：Bedrocan
Indications (approved)：Diabetic neuropathy, Hepatocellular carcinoma
Regional status
US
-
EU
Phase II
2021-04-15
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Medical Cannabis(Syqe Medical)?
Approved indications include: Diabetic neuropathy, Hepatocellular carcinoma.
When does the Medical Cannabis(Syqe Medical) patent expire?
No public expiry year is available for Medical Cannabis(Syqe Medical) yet; this page updates once verified.
How do I get a quote for Medical Cannabis(Syqe Medical) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21